Cargando…
Gene expression profiles and pathway enrichment analysis of human osteosarcoma cells exposed to sorafenib
Sorafenib is an inhibitor of a variety of tyrosine kinase receptors used to treat various cancers including hepatocellular, renal cell and thyroid carcinoma. It has been shown to change various targets associated with osteosarcoma, but the detailed mechanism remains unclear. In order to identify key...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929930/ https://www.ncbi.nlm.nih.gov/pubmed/29744300 http://dx.doi.org/10.1002/2211-5463.12428 |